NIH Grants 23andMe $1.4 Million for Genetics Research The Food and Drug Administration (FDA) has approved for marketing 23andMe's Bloom Syndrome carrier test to determine whether a healthy person ...
The U.S. Food and Drug Administration has allowed Google-backed company 23andMe to begin marketing a home genetic test for Bloom Syndrome — an inherited condition characterized by shortness of height ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results